Anaplastic large cell lymphoma and breast implants: A systematic review

Plastic and Reconstructive Surgery

Volumn 127, Issue 6, 2011, Pages 2141-2150

  Kim, Benjamin ^a,b,c,d   Roth, Carol ^a,b,c,d   Chung, Kevin C ^a,b,c,d   Young, V Leroy ^a,b,c,d   Van Busum, Kristin ^a,b,c,d   Schnyer, Christopher ^a,b,c,d   Mattke, Soeren ^a,b,c,d  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Body Aesthetic Research Center   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST ENDOPROSTHESIS; BREAST TUMOR; FEMALE; HUMAN; LARGE CELL LYMPHOMA; PATHOLOGY; REVIEW;

BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC;

EID: 79958698845     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182172418     Document Type: Review

References (54)

1. Duvic M, Moore D, Menter A, Vonderheid EC. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995;32:939-942.
2. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998;16:2780-2795. (Pubitemid 28363044)
3. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, Md: National Cancer Institute; 2010.
4. Cohen PL, Brooks JJ. Lymphomas of the breast: A clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer 1991;67:1359-1369.
5. Brogi E, Harris NL. Lymphomas of the breast: Pathology and clinical behavior. Semin Oncol. 1999;26:357-364. (Pubitemid 29272903)
6. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1705-1712.
7. Brody G, Deapen D, Gill P, et al. T-cell non Hodgkin's anaplastic lymphoma associated with one style of breast implants. Paper presented at: 89th Annual Meeting of the American Association of Plastic Surgeons; March 20-23, 2010; San Antonio, Texas.
8. American Society of Plastic Surgeons. 2010 Report of the 2009 Statistics: National Clearinghouse of Plastic Surgery Statistics. Arlington Heights, Ill: American Society of Plastic Surgeons; 2010.
9. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300: 2030-2035.
10. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: A review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009;123:790-793.
11. Lechner M, Lade S, Brody G, Epstein A. Breast implant-associated T cell anaplastic large-cell lymphoma: Case report and establishment of a novel cell line (Tlbr-1). J Invest Med. 2010;58:317.
12. Hanson SE, Gutowski KA. Primary T-cell lymphoma associated with breast implant capsule. Plast Reconstr Surg. 2010; 126:39e-41e.
13. Li S, Lee AK. Silicone implant and primary breast ALK1- negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol. 2009;3:117-127.
14. Mora P, Melo AC, Amorim GLS, Scheliga AA. Primary T-cell anaplastic lymphoma associated to a breast implant: Case report. Haematologica 2009;94:658-659.
15. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ. Anaplastic large cell lymphoma involving the breast: A clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009;133:1383-1390.
16. Gualco G, Chioato L, Harrington WJ Jr, Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: Clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol. 2009;17:301-306.
17. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: A report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009;2:237-244.
18. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: An unusual case presentation. Diagn Pathol. 2009;4:11.
19. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma 2009;50:831-833.
20. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: A case report and review of the literature. Am J Surg Pathol. 2008;32:1265-1268.
21. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: An indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008;21:455-463. (Pubitemid 351441035)
22. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: A case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008;61:822-825. (Pubitemid 351970472)
23. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg. 2007;59:56-57. (Pubitemid 46987980)
24. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer: A case report. Virchows Arch. 2006;449:561-564. (Pubitemid 44722325)
25. Kraemer DM, Tony HP, Gattenlöhner S, Müller JG. Lymphoplasmacytic lymphoma in a patient with leaking silicone implant. Haematologica 2004;89:ELT01.
26. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: A case report and review of the literature. Arch Pathol Lab Med. 2003;127:e115-e118.
27. GaudetG,FriedbergJW,WengA, PinkusGS,FreedmanAS. Breast lymphoma associated with breast implants: Two case-reports and a review of the literature. Leuk Lymphoma 2002;43:115-119. (Pubitemid 34228827)
28. Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554-555.
29. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: Report of two cases of Kaposi's sarcoma herpes virusassociated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996;88:3124-3128. (Pubitemid 26357396)
30. SendagortaE,LedoA. Sezarysyndromein association with silicone breast implant. J Am Acad Dermatol. 1995;33:1060-1061.
31. Cook PD, Osborne BM, Connor RL, Strauss JF. Follicular lymphoma adjacent to foreign body granulomatous inflammation and fibrosis surrounding silicone breast prosthesis. Am J Surg Pathol. 1995;19:712-717.
32. Jacobsen E. Anaplastic large-cell lymphoma, T-/null-cell type. Oncologist 2006;11:831-840. (Pubitemid 44157571)
33. Pittaluga S, Wlodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol. 1997;151:343-351. (Pubitemid 27330055)
34. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996;87:3437-3441.
35. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-1284. (Pubitemid 24107549)
36. Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway. Blood 2000;96:4319-4327.
37. Falini B, Pileri S, Zinzani PL, et al. ALK+lymphoma: Clinicopathological findings and outcome. Blood 1999;93:2697-2706.
38. Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-4130.
39. Savage KJ, Harris NL, Vose JM, et al. ALK- anaplastic largecell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the International Peripheral T-Cell Lymphoma Project. Blood 2008;111:5496-5504.
40. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785. (Pubitemid 40656118)
41. Liu HL, Hoppe RT, Kohler S, Harvell JD, Reddy S, Kim YH. CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol. 2003;49:1049-1058. (Pubitemid 37475476)
42. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer 1993;71: 2097-2104. (Pubitemid 23068561)
43. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: Time for it to be defined as a distinct clinico-pathological entity. Haematologica 2010;95:1977-1979.
44. Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol. 2007;127:707-722.
45. Fitch K, Bernstein SJ, Aguilar MS, Burnand B, LaCalle JR. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, Calif: RAND Corporation; 2001.
46. Santori G, Fontana I, Valente R, Ghirelli R, Valente U. Application of the RAND/UCLA Appropriateness Method to evaluate an information system for kidney/pancreas transplantation in adult recipients. Transplant Proc. 2008;40:2021-2023.
47. Santori G, Andorno E, Valente R, Ghirelli R, Valente U. Application of the RAND/UCLA appropriateness method to evaluate an informative system for liver transplantation in adult and pediatric recipients. Transplant Proc. 2007;39:1927-1929. (Pubitemid 47198830)
48. Santori G, Valente R, Cambiaso F, Ghirelli R, Gianelli Castiglione A, Valente U. Preliminary results of an expert-opinion elicitation process to prioritize an informative system funded by Italian Ministry of Health for cadaveric donor management, organ allocation, and transplantation activity. Transplant Proc. 2004;36:433-434. (Pubitemid 38534276)
49. Shekelle PG, Chassin MR, Park RE. Assessing the predictive validity of the RAND/UCLA appropriateness method criteria for performing carotid endarterectomy. Int J Technol Assess Health Care 1998;14:707-727. (Pubitemid 29029300)
50. Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: A pooled long-term follow-up study. Int J Cancer 2009;124:490-493.
51. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg. 2007;119:1987-1992. (Pubitemid 46847086)
52. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006;118:2854-2862. (Pubitemid 43673367)
53. Pukkala E, Boice JD, Jr, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants 2002;12: 271-279. (Pubitemid 36232473)
54. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol. 2001;11: 248-256. (Pubitemid 32288854)